Does TACROLIMUS Cause Thrombophlebitis superficial? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Thrombophlebitis superficial have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.0% of all adverse event reports for TACROLIMUS.
12
Reports of Thrombophlebitis superficial with TACROLIMUS
0.0%
of all TACROLIMUS reports
1
Deaths
7
Hospitalizations
How Dangerous Is Thrombophlebitis superficial From TACROLIMUS?
Of the 12 reports, 1 (8.3%) resulted in death, 7 (58.3%) required hospitalization, and 1 (8.3%) were considered life-threatening.
Is Thrombophlebitis superficial Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Thrombophlebitis superficial?
DROSPIRENONE\ETHINYL ESTRADIOL (160)
LENALIDOMIDE (121)
ETHINYL ESTRADIOL\ETONOGESTREL (93)
RIVAROXABAN (82)
YAZ (78)
YASMIN (65)
TESTOSTERONE (62)
HUMAN IMMUNOGLOBULIN G (43)
ADALIMUMAB (40)
CAPECITABINE (29)
Which TACROLIMUS Alternatives Have Lower Thrombophlebitis superficial Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB